跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 48 条关于
“EWSR1”
全部
48
临床试验
22
药物
0
机构
0
资讯
26
11个月前
FDA Clears Lirum's LX-101 for Inclusion in RAPID Platform Trial for Rare Pediatric Cancers
上个月
Genomic Profiling of High-Risk Pediatric Tumors Reveals Actionable Alterations in Nearly One-Quarter of Patients
5个月前
Lirum Therapeutics' LX-101 Shows Promising Preclinical Activity in Ewing Sarcoma, Advances to RAPID Platform Trial
5个月前
Trabectedin-Irinotecan Combination Shows Promise Against EWS::FLI1 Fusion in Ewing Sarcoma Phase 1/2 Trial
2个月前
Multi-Antigen T Cell Therapy Shows Safety and Durable Responses in Pediatric Brain Tumors: Phase 1 ReMIND Trial
3年前
ASCO Updates Guidelines: ESR1 Mutation Testing Recommended for Advanced Breast Cancer
去年
ESR1 Mutations in Breast Cancer: Emerging Biomarker Reshapes Treatment Strategies
去年
Elacestrant Demonstrates Efficacy in ESR1-Mutated, Endocrine-Sensitive Breast Cancer
去年
ESR1 Mutation Testing Gains Importance in HR-Positive Breast Cancer Treatment
4个月前
FDA Approves First PROTAC Drug VEPPANU for ESR1-Mutated Breast Cancer
第 1 页,共 3 页
上一页
下一页